Leading the way in Europe to bring
microbiome-based innovations to market.

logo apm fullwhite

Alliance Promotion Microbiote (APM) brings together innovative French stakeholders interested in the advancement of the microbiome industry.

Our mission

APM is collectively building a dynamic ecosystem positioning France as a European leader in the development, production and marketing of scientific and therapeutic innovations linked to the microbiome.

About us

APM gathers more than 20 key private and public players supporting each other’s efforts to develop tomorrow’s medicine based on microbiome diagnostic and therapeutic innovations.

> MORE

about us apm
white form apm

APM is currently focused on advancing key topics for microbiome innovations to reach the market, clarifying the regulatory pathways for microbiome-related therapies and fostering awareness about the key role of the microbiome in health and disease.

increase clarity

Increase the clarity
of regulatory pathways

awareness

Foster the awareness
about the major role of the
microbiome in health and disease.

Our members

APM brings together more than 20 key private and public players committed to develop tomorrow’s medicine based on microbiome diagnostic and therapeutic innovations.

being a member

Join us!

Unity is strength. Joining APM means being able to provide input to policy makers, patients’ associations, investors in Europe, and share networking opportunities while contributing to structure the industry.

News

white form apm
News
23/01/2024
Focus SoHO et Paquet Pharma
> READ
white form apm
News
09/11/2023
Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members
> READ
white form apm
News
24/08/2023
Alliance Promotion Microbiote applauds the new legislation securing stool collection in France
> READ